# BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV

> **NCT02817802** · — · UNKNOWN · sponsor: **Biotronik AG** · enrollment: 2066 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Magmaris

## Key facts

- **NCT ID:** NCT02817802
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2020-07-14
- **Final completion:** 2025-10
- **Target enrollment:** 2066 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02817802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02817802, "BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02817802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*